OX2 Therapeutics logo

OX2 Therapeutics jobs and careers

Minneapolis, MN, United States

About OX2 Therapeutics

OX2 Therapeutics is a healthcare therapeutics company that focuses on treating brain tumors. Its novel CD200 Checkpoint peptide inhibitor activates the immune system through a CD200 activation receptor, enabling healthcare institutes to apply receptor antibodies that permit the immune system army to pass through blood vessel walls and kill canceractivities.

Founded in 2016 by Christopher Moertel and Sumant Dhawan.

Founded
2016
Employees
1 to 10
Total funding
$649K
Headquarters
Minneapolis

Jobs at OX2 Therapeutics

No open positions right now. Explore more companies on TheJobsMap.